The company offers contract manufacturing of ophthalmic/otic and sterile injectables products, for pharmaceutical and biotech firms.
JHP Pharma’s sterile manufacturing facility, situated in Rochester Michigan and covers over 80 acres of land and includes a 171,000sqft production building and warehouse.
JHP Pharma president and CEO Stuart Hinchen said during the last seven months, they have completed FDA and EMA audits and entered agreements with five new customers.